![](/img/cover-not-exists.png)
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro
Claudio Festuccia, Giovanni Luca Gravina, Adriano Angelucci, Danilo Millimaggi, Paola Muzi, Carlo Vicentini, Mauro BolognaVolume:
115
Year:
2005
Language:
english
Pages:
11
DOI:
10.1002/ijc.20917
File:
PDF, 618 KB
english, 2005